@FierceBiotech: In Alzheimer's mystery, key biomarker will determine success of pivotal studies. Story | Follow @FierceBiotech
@JohnCFierce: At the very least, Merck should redesign the patient selection process on MK-8931 and concentrate on mild/prodromal Alzheimer's cases only. | Follow @JohnCFierce
@RyanMFierce: AstraZeneca has answered German price cuts to drugs with $AZN workforce cuts of 400-650 workers in the country. Release | Follow @RyanMFierce
> Lundbeck CEO Ulf Wiinberg predicts 2013 to bring a "feast" of potential regulatory wins after battling generics competition. Article
> Biogen Idec ($BIIB) CEO George Scangos is featured in a Forbes article on the big biotech's comeback. Item
> FDA staff out the potential for abuse of Zogenix's pain drug. Item
> Peregrine ($PPHM) says (again) that the FDA has cleared the company's plans for late-stage development of Cotara for treating brain tumors. Report
> GlaxoSmithKline ($GSK) has raised doubts about diabetes drugs in the GLP-1 class serving as obesity treatments. Article
Pharma News
@FiercePharma: Eli Lilly taps India's Strides Arcolab to make/distribute generic cancer drugs in emerging markets. More | Follow @FiercePharma
> Indian bureaucrats decide to review all foreign pharma investments. More
> Closely watched Novartis patent case wraps in India. Story
> AZ blames German pricing for 400 job cuts. Article
@FierceMedDev: SurgiQuest pulled in $18.5M in new funding for an abdominal cavity surgical tool. Release | Follow @FierceMedDev
@MarkHFierce: Another day, another lawsuit against a faulty metal hip replacement--this time against Biomet. Story | Follow @MarkHFierce
@DamianFierce: The Israeli medical device industry is on the up-and-up, and Medtronic is paying attention, an exec says. News | Follow @DamianFierce
> Device startup nails $3.64M Series A for hemorrhage-control device. Item
> Kona Medical closes $40M round for renal denervation device. News
Drug Delivery News
> Leukemia nanoparticles get drugs to the right spot. News
> Team shoos away superbugs with puffs of powder. Report
> Iluvien stumbles on rocky road to market in U.K. Article
> Dissolving fabric could stop pregnancy, HIV. Story
Biomarkers News
> Experts: Britain's NHS must build genetic testing infrastructure. News
> In Alzheimer's mystery, key biomarker will determine success of pivotal studies. Article
> Supreme Court to tackle gene patent case. Item
> Gene analysis marks new targets against childhood cancer. Report
> Biotech grabs $2M to discover biomarkers for personalized autism treatment. News
> Biomarker spotted for colon cancer stem cells. Story
And Finally… Sanofi ($SNY) strategy chief David-Alexandre Gros has joined the small but growing number of pharma execs talking up transparency of raw data from clinical trials. Report